Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.15 million shares were traded. HSTM stock price reached its highest trading level at $28.21 during the session, while it also had its lowest trading level at $28.0.
Ratios:
For a better understanding of HSTM, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.20. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 03, 2024, initiated with a Overweight rating and assigned the stock a target price of $32.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 27 ’25 when KEVIN PATRICK O’HARA bought 2,000 shares for $28.00 per share.
O’Hara Kevin P sold 2,000 shares of HSTM for $55,936 on Aug 27 ’25. The Executive Vice President now owns 17,137 shares after completing the transaction at $27.97 per share. On Feb 27 ’25, another insider, Fenstermacher Scott, who serves as the Senior Vice President of the company, sold 2,000 shares for $33.15 each. As a result, the insider received 66,300 and left with 12,327 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSTM now has a Market Capitalization of 832324864 and an Enterprise Value of 757597120. As of this moment, Healthstream’s Price-to-Earnings (P/E) ratio for their current fiscal year is 42.21, and their Forward P/E ratio for the next fiscal year is 38.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.82 while its Price-to-Book (P/B) ratio in mrq is 2.39. Its current Enterprise Value per Revenue stands at 2.566 whereas that against EBITDA is 19.176.
Stock Price History:
The Beta on a monthly basis for HSTM is 0.48, which has changed by -0.021261752 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, HSTM has reached a high of $34.24, while it has fallen to a 52-week low of $25.36. The 50-Day Moving Average of the stock is 4.31%, while the 200-Day Moving Average is calculated to be -7.34%.
Shares Statistics:
Over the past 3-months, HSTM traded about 187.24K shares per day on average, while over the past 10 days, HSTM traded about 202150 shares per day. A total of 29.90M shares are outstanding, with a floating share count of 23.45M. Insiders hold about 20.88% of the company’s shares, while institutions hold 76.01% stake in the company. Shares short for HSTM as of 1755216000 were 825278 with a Short Ratio of 4.41, compared to 1752537600 on 641205. Therefore, it implies a Short% of Shares Outstanding of 825278 and a Short% of Float of 5.07.
Earnings Estimates
As of right now, 2.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.19, with high estimates of $0.2 and low estimates of $0.18.
Analysts are recommending an EPS of between $0.84 and $0.67 for the fiscal current year, implying an average EPS of $0.75. EPS for the following year is $0.81, with 2.0 analysts recommending between $0.87 and $0.75.
Revenue Estimates
5 analysts predict $75.52M in revenue for the current quarter. It ranges from a high estimate of $75.9M to a low estimate of $74.78M. As of the current estimate, Healthstream Inc’s year-ago sales were $73.09MFor the next quarter, 5 analysts are estimating revenue of $76.53M. There is a high estimate of $77.01M for the next quarter, whereas the lowest estimate is $76.02M.
A total of 5 analysts have provided revenue estimates for HSTM’s current fiscal year. The highest revenue estimate was $300.5M, while the lowest revenue estimate was $298.67M, resulting in an average revenue estimate of $299.91M. In the same quarter a year ago, actual revenue was $291.65MBased on 5 analysts’ estimates, the company’s revenue will be $315.3M in the next fiscal year. The high estimate is $317.4M and the low estimate is $309.81M.
